C-BI27Puretech
validated efficacy, oral administration, tolerability
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-BI27
C-BI27C-BI27validated efficacy, oral administration, tolerability
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Puretech validated efficacy, oral administration, tolerability
PureTech Health says it is dedicated to giving life to science and transforming innovation into value. Its R&D engine has generated 29 new therapeutics and therapeutic candidates, with three taken from inception at PureTech to U.S. FDA approval. The company focuses on enhancing on-target efficacy, enabling oral administration, or improving tolerability to unlock new classes of medicine.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Puretech — Near-term readout · Bottom quartile. Derived deterministically from 7 extracted project(s). Most-advanced status: phase 3. Band: near_readout. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic